Literature DB >> 11950405

Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage.

Jose G Romano1, Alejandro M Forteza, Mauricio Concha, Sebastian Koch, Roberto C Heros, Jacques J Morcos, Viken L Babikian.   

Abstract

OBJECTIVE: To determine the frequency and characteristics of microembolic signals (MES) in subarachnoid hemorrhage (SAH).
METHODS: Twenty-three patients with aneurysmal SAH were monitored with transcranial Doppler ultrasonography for the presence of MES and vasospasm. Each middle cerebral artery was monitored for 30 minutes three times each week. Patients were excluded if they had traumatic SAH or cardiac or arterial sources of emboli. Monitoring was initiated 6.3 days (1-16 d) after SAH and lasted 6.6 days (1-13 d). Eleven individuals without SAH or other cerebrovascular diseases who were treated in the same unit served as control subjects. Each patient underwent monitoring of both middle cerebral arteries a mean of three times; therefore, 46 vessels were studied (a total of 138 observations). Control subjects underwent assessment of each middle cerebral artery once, for a total of 22 control vessels.
RESULTS: MES were detected for 16 of 23 patients (70%) and 44 of 138 patient vessels (32%) monitored, compared with 2 of 11 control subjects (18%) and 2 of 22 control vessels (9%) (P < 0.05). MES were observed for 83% of patients with clinical vasospasm and 54% of those without clinical vasospasm. Ultrasonographic vasospasm was observed for 71 of 138 vessels monitored; MES were observed for 28% of vessels with vasospasm and 36% of those without vasospasm. Aneurysms proximal to the monitored artery were identified in 38 of 138 vessels, of which 34% exhibited MES, which is similar to the frequency for vessels without proximal aneurysms (31%). Coiled, clipped, and unsecured aneurysms exhibited similar frequencies of MES.
CONCLUSION: MES were common in SAH, occurring in 70% of cases of SAH and one-third of all vessels monitored. Although MES were more frequent among patients with clinical vasospasm, this difference did not reach statistical significance. We were unable to demonstrate a relationship between ultrasonographic vasospasm and MES, and the presence of a proximal secured or unsecured aneurysm did not alter the chance of detection of MES. Further studies are required to determine the origin and clinical relevance of MES in SAH.

Entities:  

Mesh:

Year:  2002        PMID: 11950405     DOI: 10.1097/00006123-200205000-00016

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  25 in total

1.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

2.  Timing of Mean Transit Time Maximization is Associated with Neurological Outcome After Subarachnoid Hemorrhage.

Authors:  J Caspers; C Rubbert; B Turowski; D Martens; D C Reichelt; R May; J Aissa; D Hänggi; N Etminan; C Mathys
Journal:  Clin Neuroradiol       Date:  2015-05-05       Impact factor: 3.649

Review 3.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

4.  Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis.

Authors:  F Cagnazzo; I Derraz; P-H Lefevre; G Gascou; C Dargazanli; C Riquelme; P Perrini; D di Carlo; A Bonafe; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-06       Impact factor: 3.825

Review 5.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 6.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

Review 7.  Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage.

Authors:  Lewis Z Leng; Matthew E Fink; Costantino Iadecola
Journal:  Arch Neurol       Date:  2010-09-13

Review 8.  Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.

Authors:  Julia C Durrant; Holly E Hinson
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

9.  Acute-stage diffusion-weighted magnetic resonance imaging for predicting outcome of poor-grade aneurysmal subarachnoid hemorrhage.

Authors:  Kenichi Sato; Hiroaki Shimizu; Miki Fujimura; Takashi Inoue; Yasushi Matsumoto; Teiji Tominaga
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-06       Impact factor: 6.200

10.  Cerebral Microembolism in Intracerebral Hemorrhage: A Prospective Case-Control Study.

Authors:  Eva A Rocha; Felipe Rocha; Izadora Deliberalli; João Brainer C de Andrade; Irapuá F Ricarte; Aneesh B Singhal; Gisele S Silva
Journal:  Neurocrit Care       Date:  2020-08-07       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.